Response to Letter Regarding Article, "Efficacy and Safety of Omalizumab Combined With Allergen Immunotherapy in Children With Moderate to Severe Allergic Asthma"

Int Forum Allergy Rhinol. 2025 Jul 2:e23637. doi: 10.1002/alr.23637. Online ahead of print.

Authors

Wenxin Shen¹, Qianlan Zhou¹, Qinzhen Zhang¹, Lina Han¹, Li Chen¹, Xiaowen Li¹, Bing Dai¹, Si Liu¹, Lishen Shan¹

Affiliation

¹ Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.

PMID: 40600912
DOI: 10.1002/alr.23637

No abstract available

Publication types

Letter